# PTH: Caution Merited Given Weak Risk-Adjusted Returns

> Investor warns PTH ETF's weak risk-adjusted returns warrant caution.
- Title: PTH: Caution Merited Given Weak Risk-Adjusted Returns
- Summary: Investor warns PTH ETF's weak risk-adjusted returns warrant caution. Investor Vasily Zyryanov initiates coverage of PTH with a Hold rating due to poor…
- Keywords: invesco dorsey wright healthcare momentu, pth, risk-adjusted returns, ivv, xlv, healthcare momentum, biotechnology, Seekingalpha
- Source: Seekingalpha — https://seekingalpha.com/article/4968210-pth-caution-merited-given-weak-risk-adjusted-returns
- Published: 2026-11-14T17:38:12+00:00
- Read time: 1 min
- Topics: invesco dorsey wright healthcare momentu, pth, risk-adjusted returns, ivv, xlv, healthcare momentum, biotechnology, money, business
## Investor initiates PTH coverage
Vasily Zyryanov initiates coverage of the Invesco Dorsey Wright Healthcare Momentum ETF with a Hold rating.
## PTH's portfolio strength
PTH's biotechnology-heavy portfolio has strong weighted average Quant and Wall Street ratings.
## Weak performance since 2014
PTH's performance since 2014 has been lackluster compared to IVV and XLV, especially in risk-adjusted returns and maximum drawdowns.
## Questionable portfolio quality
PTH's portfolio has excessive exposure to EBITDA- and cash flow-negative companies.
## Key takeaway

Investor Vasily Zyryanov initiates coverage of PTH with a Hold rating due to poor risk-adjusted performance since 2014.